Covaxin Efficacy Yet to be Reviewed by Govt, Bharat Biotech to Submit Data in 2-3 Days: Report

Bharat Biotech, which developed the drug that has shown an efficacy of 81% in the initial phase 3 trial analysis, would submit the clinical trial data to the government in the coming days for review, said a senior official at CDSCO, which is under the Drugs Controller General of India (DCGA).

source https://www.news18.com/news/india/covaxin-efficacy-yet-to-be-reviewed-by-govt-bharat-biotech-to-submit-data-in-2-3-days-report-3500192.html